Rotavirus vaccine effectiveness and impact in Uzbekistan, the first country to introduce in central Asia

Rotavirus vaccine effectiveness and impact in Uzbekistan, the first country to introduce in central Asia

Uzbekistan, the most populous country in central Asia, was the first in the region to introduce rotavirus vaccine into its national immunization program. Rotarix (GlaxoSmithKline Biologicals, RV1) was introduced in June 2014, with doses recommended at age 2 and 3 months. To evaluate vaccine impact,...

Full description

Bibliographic Details
Main Authors: Umid Eraliev, Renat Latipov, Dilorom Tursunova, Annemarie Wasley, Danni Daniels, Umed Ismoilov, Manzura Akramova, Mehri Sultanova, Dilbar Yuldashova, Bahodir Barakaev, Vazira Mutalova, Laziz Tuychiev, Erkin Musabaev, Said Sharapov, Boris Pleshkov, Dovile Videbaek, Shahin Huseynov, Kamola Safaeva, Slavica Mijatovic-Rustempasic, Michael D. Bowen, Umesh D. Parashar, Margaret M. Cortese
Format: Article
Language:English
Published: Taylor & Francis Group 2021-02-01
Series:Human Vaccines & Immunotherapeutics
Subjects:
rotavirus vaccine
uzbekistan
rotavirus
vaccine effectiveness
vaccine impact
children
Online Access:http://dx.doi.org/10.1080/21645515.2020.1776034

Internet

http://dx.doi.org/10.1080/21645515.2020.1776034

Similar Items